BNR Competitors & Alternatives
Compare Burning Rock Biotech Ltd with similar stocks in the same industry
Diagnostics & Research
BNR
Main Stock$13.25
Tradestie Score
66
Market Cap
$93.35M
Revenue Growth
-0.1%
Analyst Upside
-69.6%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$16.49
|
$1.13B | - | 46 | Compare |
|
CDNA
CareDx, Inc.
|
$76.33
|
$798.40M | 36.2 | 25 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.66
|
$719.31M | - | 61 | Compare |
|
MYGN
Myriad Genetics Inc
|
$6.29
|
$719.23M | - | 36 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$14.84
|
$718.62M | 6.6 | 50 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.20
|
$667.77M | - | 39 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.55
|
$612.76M | - | 48 | Compare |
|
NBP
NBP
|
$0.91
|
$117.16M | - | 38 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$3.56
|
$85.47M | - | 33 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$3.46
|
$25.84M | - | 61 | Compare |
More BNR Analysis
Data updated: Nov 06, 2026 | Industry: Diagnostics & Research (SIC 8071)
40 stocks in this industry